Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 216 results
A minimalist illustration of a bronchoscope in a dark palette.

Aug 17, 2026

Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software

Johnson & Johnson MedTech has unveiled Monarch Quest 3, a new software update for its robotic bronchoscopy platform, following FDA 510(k) clearance. This marks the fourth enhancement to the Monarch system in just 18 months, reflecting the company's commitment to advancing lung cancer diagnostics.The Monarch platform is designed to assist clinicians with real-time visualization and precise control during lung biopsies. The latest software iteration introduces significant improvements such as enha
Minimalist illustration of a diagnostic device and test sample in flat design.

Aug 17, 2026

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710

This week, IDEXX Laboratories has made significant strides in expanding its diagnostics and AI software offerings, while Barclays adjusted its price target for the company.IDEXX Laboratories (NASDAQ:IDXX) is enhancing its diagnostics capabilities and expanding its AI software suite, which has contributed to a reported double-digit growth in recurring revenue. The company has projected a future increase in recurring revenue of 8.5% to 11%, alongside maintaining operating margins exceeding 32%. Th
Press release cover image

Aug 17, 2026

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program

The new grant brings the total AI grants approved for Pulsenmore over the past month to approximately $1.6 million, supporting two programs with a combined scope of approximately $3.12 million.The program is designed to advance the next generation of home ultrasound through AI-powered real-time ultrasound analysis and dynamic guidance of the image acquisition process, with the goal of improving scan quality and consistency and enabling home ultrasound to be deployed at greater scale.RAMAT GAN, I
A sleep mask on a pillow in a sleep lab

Aug 14, 2026

AI Sleep Diagnostics

HoneyNaps has recently achieved FDA 510(k) clearance for its SOMNUM V3.0, an innovative AI-driven platform aimed at enhancing polysomnography analysis for clinicians.This platform utilizes advanced algorithms to automatically identify and categorize apnea and hypopnea events, distinguishing between obstructive, central, and mixed types. Validation data presented to the FDA indicated an impressive 97% Overall Percent Agreement across various respiratory event classifications. Building on previous
Minimalist illustration of lungs with highlighted airways

Aug 14, 2026

LTTS Has NVIDIA-Driven AI Lung Digital Twin Solution

L&T Technology Services has unveiled an innovative AI-driven digital twin platform aimed at enhancing respiratory diagnostics and surgical planning.This next-generation platform integrates LTTS' expertise in medical technology with NVIDIA's AI capabilities, focusing on lung navigation and diagnostics. By utilizing advanced imaging techniques and deep learning, it creates detailed 3D digital representations of the lungs, allowing healthcare professionals to visualize critical anatomical features
Flat illustration of a medical imaging device

Aug 14, 2026

AI-Powered Imaging Diagnostics Market Size to Reach USD 14.92

The AI-powered imaging diagnostics market is projected to grow significantly, reaching USD 14.92 billion by 2035, driven by increasing integration of AI technologies in various medical fields.Radiology remains the dominant application area for AI in imaging diagnostics, with expanding use in cardiology, oncology, neurology, and ophthalmology. Healthcare providers are transitioning from pilot projects to full integration of AI into everyday imaging workflows, aiming to enhance productivity and ma
A stethoscope and circuit board silhouette representing diagnostic AI.

Aug 12, 2026

Aidoc teams with 12 health systems to tackle issues around diagnostics

Aidoc has launched a Diagnostic AI Consortium, uniting twelve prominent U.S. health systems to enhance the evaluation and governance of diagnostic AI technologies.The consortium includes major players like Advocate Health, Cedars-Sinai, and Mount Sinai, with a focus on creating shared standards for the deployment and assessment of diagnostic AI. Aidoc's CEO, Elad Walach, emphasized the importance of collaboration in developing AI tools that are rigorously validated for clinical use and capable o
Press release cover image

Aug 12, 2026

Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging

TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV: VPT; OTC: VPTDF), a leader in AI-assisted cardiac imaging, today announced the next phase of its commercial strategy for VMS+™ 4.0, its FDA-cleared platform that turns standard heart-ultrasound images into three-dimensional cardiac measurements. The Company is expanding subscription-based access, hospital demonstrations, and customer-engagement programs to help more hospitals evaluat
Press release cover image

Aug 12, 2026

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflowDesigned to reduce scan time, support faster technologist onboarding and deliver more reproducible results across imaging centersExtends Aclarion's IP protection to over 65 issued and pending patents worldwide, complementing its broader portfolio covering spectroscopy acquisition, data processing, biomarkers and analytics BROOMFIELD, Colo., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aclario
A minimalist representation of an X-ray film highlighting a bone structure in lime green against a dark background.

Aug 12, 2026

5 Companies Using AI to Transform Diagnostics and Medical Imaging

AI is revolutionizing diagnostics and medical imaging, enabling healthcare providers to enhance efficiency and accuracy in clinical decision-making.The integration of artificial intelligence in healthcare is transforming how diagnoses are made, particularly in medical imaging. AI technologies are being utilized to analyze various diagnostic data, including X-rays and CT scans, assisting professionals in identifying abnormalities and prioritizing urgent cases. This shift is crucial as healthcare
Press release cover image

Aug 12, 2026

VB Spine Completes Transaction for CT-Fluoro Technology from Augmedics

CT-Fluoro technology will be integrated into VB Spine’s growing xvision platformNEW YORK--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), the largest privately held spine company, today announced it has completed its acquisition of the exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications and will immediately begin integrating the technology into the xvision Spine System® platform."We are pleased to complete this transaction and continue building on the momen
Press release cover image

Aug 12, 2026

Nucleai Advances AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration

Collaboration demonstrates how AI-powered Tissue Intelligence is transforming biomarker discovery, translational research, and precision oncology development.TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, a leader in AI-powered Tissue Intelligence, which integrates multimodal tissue image analysis with clinical data to deliver translational insights, today announced an ongoing translational research collaboration with Gilead Sciences supporting its global antibody-drug conjugate (ADC) clinical deve